Takotsubo Cardiomyopathy: Another Form of Cardiorenal Syndrome

Verena Bill1,2, Ibrahim El-Battrawy1,2, Ursula Hoffmann1,2

  • 11 First Department of Medicine Cardiology, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.

Angiology
|July 11, 2017
PubMed

Insights

Kidney failure significantly worsens outcomes for patients with Takotsubo cardiomyopathy (TC), leading to higher mortality rates. This finding highlights the critical link between cardiac and renal health in TC prognosis.

Area of Science:

  • Cardiology
  • Nephrology
  • Critical Care Medicine

Background:

  • Takotsubo cardiomyopathy (TC) is a serious heart condition with unclear causes.
  • The relationship between heart and kidney failure is known, but its impact on TC outcomes is not.
  • Existing research lacks data on how kidney failure affects Takotsubo cardiomyopathy prognosis.

Purpose of the Study:

  • To investigate the influence of kidney failure (KF) on the outcomes of patients with Takotsubo cardiomyopathy (TC).
  • To compare the long-term prognosis of TC patients with and without co-existing kidney failure.

Main Methods:

  • A retrospective cohort study of 114 consecutive Takotsubo cardiomyopathy patients from January 2003 to September 2015.
  • Patients were divided into two groups: those with kidney failure (n=32) and those without (n=76).
  • The study assessed a composite endpoint including in-hospital events, all-cause mortality, heart failure rehospitalization, stroke, and TC recurrence over a 5-year follow-up.

Main Results:

  • No significant differences in baseline characteristics were observed between patients with and without kidney failure.
  • Patients with kidney failure experienced significantly higher mortality rates at 1, 2, and 5 years post-event (21.8% vs 7.9%, 31.5% vs 11.8%, and 43.7% vs 22.3%, respectively).
  • No differences were found in life-threatening arrhythmias, cardiogenic shock, or thromboembolic events during the index event between the groups.

Conclusions:

  • Co-existing kidney failure is associated with a substantially worse long-term prognosis for Takotsubo cardiomyopathy patients.
  • The findings underscore the clinical relevance of kidney function in managing TC.
  • Further research is needed to elucidate the underlying mechanisms connecting kidney failure and adverse TC outcomes.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
700
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
651
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
641
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K